Aging cell model and preparation method thereof
A cell model and stem cell technology, applied in the biological field, can solve the problems of clinical translational research limitations, inability to understand human aging, and large differences.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0071] Example 1. Establishment and identification of ATF6-deficient embryonic stem cell lines
[0072] This embodiment relates to the targeted inactivation of the human ATF6 gene in human embryonic stem cells (the genome sequence is GenBank: NC_000001.11 at No. 161,766,244-161,964,070, updated on PRI 12-JUL-2017; the cDNA sequence is GenBank: NM_007348 .3, updated on PRI 10-JUL-2017), to disable ATF6 function, and obtain human embryonic stem cells with ATF6 function loss. Since the biological function of ATF6β is rarely reported, ATF6 is directly used to represent ATF6α, that is, ATF6 in this paper is ATF6α.
[0073] The present invention firstly designs and obtains the homology arm sequence targeting at both sides of the No. 1 exon of the ATF6 gene in the human genome by molecular cloning methods, and then constructs it into the pCR2. Gift from Professor Belmonte, recorded in "Duan, S., Yuan, G., Liu, X., Ren, R., Li, J., Zhang, W., Wu, J., Xu, X., Fu, L ., Li, Y., et al. ...
Embodiment 2
[0129] Example 2, Preparation of ATF6- / -MSC by Directed Differentiation of ATF6- / -ESC in vitro
[0130] In the present invention, the ATF6- / -ESCs obtained in Example 1 were further differentiated into mesenchymal stem cells (ATF6- / -MSCs) in vitro, and it was found that ATF6- / -MSCs could exhibit typical cell senescence symptoms.
[0131] The specific method is as follows:
[0132] 1. Directed differentiation of ATF6- / - mesenchymal stem cells
[0133] ATF6- / -ESCs were differentiated into embryoid bodies (EBs) for 14 days, and EBs were seeded in matrigel (Invitrogen)-coated 6-well plates for culture, and cultured for 2 weeks until fibrous cells appeared . After another passaging, the cell populations in which CD73, CD90 and CD105 were all positive were sorted by flow cytometry ( figure 2 Middle A) are ATF6-deficient (ATF6- / -) mesenchymal stem cells (denoted as ATF6- / -MSC). In the present invention, the H9 cell line is directedly induced to differentiate into mesenchymal stem...
Embodiment 3
[0168] Example 3. Detecting the cell phenotype caused by the imbalance of protein homeostasis produced by ATF6- / - MSC cells induced by stimulators.
[0169] In the present invention, during the process of culturing the aforementioned ATF6- / -MSCs derived from ATF6- / -ESCs, abnormalities in protein homeostasis of cells are detected. details as follows:
[0170] When intracellular protein homeostasis is out of balance, intracellular misfolded proteins increase, and abnormal proteins cannot be degraded, resulting in a significant increase in intracellular protein aggregates. After ATF6+ / + MSC (wild type) and ATF6- / - MSC cells were cultured normally to the late passage (10th passage), the cells were digested and collected, and the probes for labeling protein aggregates (ENZO, ENZ-51035-K100PROTEOSTAT Agresome detection kit ) for staining of wild-type and ATF6- / - MSCs. The specific analysis method is as follows:
[0171] 1) Digest and collect cells, centrifuge at 1000 rpm for 5 mi...
PUM
Property | Measurement | Unit |
---|---|---|
Molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com